期刊文献+

高脂饲料诱导的胰岛素抵抗大鼠骨骼肌己糖胺通路流量的变化 被引量:1

Changes in the flux of hexosamine biosynthesis pathway in skeletal muscle of rats with insulin resistance induced by high fat diet
原文传递
导出
摘要 目的探讨己糖胺通路(HBP)在高脂饲料诱导胰岛素抵抗形成中的作用。方法雄性sD大鼠随机分为3组:对照组、高脂组和罗格列酮组。13周后,检测大鼠血清甘油三酯(TG)、总胆固醇(TC)、游离脂肪酸(FFA)、骨骼肌中TG和FFA的含量,胰岛素敏感性采用胰岛素敏感指数(ISI)和高胰岛素正糖钳夹试验稳态时的葡萄糖输注率(GIR)来评估,骨骼肌HBP的流量用谷氨酰胺:6-磷酸果糖转氨酶(GFAT)mRNA的表达水平、二磷酸尿嘧啶-N-乙酰葡萄糖胺(UDP—GlcNAc)的含量及蛋白O—GlcNAc糖基化水平来衡量。结果高脂组大鼠与对照组相比,血清TG、TC、FFA以及骨骼肌TG、FFA均升高(均P〈0.01);ISI、GIR均降低(均P〈0.01),骨骼肌GFATmRNA的表达(0.51±0.05对0.18±0.02)、UDP—GlcNAc含量[(6.18±0.86对2.42±0.36)nmol/g]以及蛋白O—GlcNAc糖基化水平均明显升高(均P〈0.01)。罗格列酮组大鼠与高脂组相比,血清和骨骼肌TG、FFA明显降低(均P〈0.01),胰岛素敏感性提高(P〈0.05),GFATmRNA的表达(0.27±0.03)、UDP—GlcNAc含量[(2.62±0.32)nmol/g]以及蛋白O—GlcNAc糖基化水平均明显降低(均P〈0.05)。结论高脂饲料诱导大鼠胰岛素抵抗与其增加骨骼肌HBP的流量相关,可被罗格列酮降低。 Objective To investigate the effect of hexosamine biosynthesis pathway on the development of insulin resistance induced by high fat diet. Methods Normal male SD rats were randomly divided into three groups: control(fed with normal chow), high fat (fed with high fat diet for 13 weeks), and rosiglitazone (intragastric administration with rosiglitazone for 5 weeks )groups. After 13 weeks, all the rats were sacrificed, serum and muscle triglycerides( TG), serum total cholesterol (TC), and serum and muscle free fatty acids (FFA) were measured. Insulin sensitivity was evaluated by insulin sensitivity index (ISI)and glucose infused rat(GIR) with the hyperinsulinemic euglycemic clamp technique. The flux of HBP in skeletal muscle was detected with the expression level of glutamine-fiuctose-6-phosphate transaminase (GFAT) mRNA ( RT-PCR), the content of UDP- GlcNAc (HPLC) and the level of O-GlcNAc glycosylation in skeletal muscle proteins (Western blot ). Results Compared with control group, serum TG, TC, FFA and muscle TG, FFA levels of high fat group increased( all P〈0.01 ), both ISI and GIR decreased( both P〈0.01 ), and the levels of GFAT mRNA (0.51 ± 0.05 vs 0. 18± 0.02), UDP-GlcNAc[ (6.18±0.86 vs 2.42±0.36) nmol/g], and O-GlcNAc glycosylation of skeletal muscle proteins in high fat group were raised ( all P〈0. 01 ). In rosiglitazone group, serum and muscle TG, FFA were deceased( all P〈0. 01 ), insulin sensitivity was increased ( P〈0. 05 ) and the flux of HBP[ GFAT mRNA 0. 27±0. 03 , UDP-GlcNAc(2.62±0.32)nmol/g] was reduced (all P〈0.05) as compared with high fat group. Conclusions High fat diet-induced insulin resistance in rats is correlated with the increased flux of HBP in skeletal muscle, which is decreased by rosiglitazone.
出处 《中华内分泌代谢杂志》 CAS CSCD 北大核心 2010年第1期43-46,共4页 Chinese Journal of Endocrinology and Metabolism
基金 基金项目:国家自然科学基金资助项目(30572076)
关键词 己糖胺通路 胰岛素抵抗 高脂饲料 罗格列酮 Hexosamine biosynthesis pathway Insulin resistance High fat diet Rosiglitazone
  • 相关文献

参考文献1

二级参考文献26

  • 1Zierath JR, Ryder JW, Doebber T, Woods J, Wu M, Ventre J, et al. Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) action. Endocrinology 1998; 139: 5034-41.
  • 2Robins S, Collins D, Wittes J, Papademetriou V, Deedwania P,Schaefer E, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events. VA-HIT: a randomized con-trolled trial. J Am Med Assoc 2001, 285: 1585-91.
  • 3Diabetes Atherosclerosis Intervention Study Investigators. Effect of fenofibrate on progression of coronary artery disease in type 2 diabetes: The Diabetes Atherosclerosis Intervention Study,a randomised study. Lancet 2001; 357: 905-10.
  • 4Tang L, Yu J, Leng Y, Feng Y, Yang Y, Ji R. Synthesis and insulin-sensitizing activity of a novel kind of benzopyran derivative. Bioorg Med Chem Lett 2003; 13: 3437-40.
  • 5Chakrabarti R, Misra P, Vikramadithyan RK, Premkumar M,Hiriyan J, Datla SR, et al. Antidiabetic and hypolipidemic potential of DRF 2519-a dual activator of PPAR-alpha and PPAR-gamma. Eur J Pharmacol 2004; 491:195 206.
  • 6Haluzik M, Colombo C, Gavrilova O, Chua S, Wolf N, Chen M, et al. Genetic background (C57BL/6J versus FVB/N) strongly influences the severity of diabetes and insulin resistance in ob/ob mice. Endocrinology 2004; 145: 3258-64.
  • 7Ljung B, Bamberg K, Dahllof B, Kjellstedt A, Oakes ND, Ostling J, et al. AZ242, a novel PPARα/γ agonist with beneficial effects on insulin resistance and carbohydrate and lipid metabolism in ob/ob mice and obese Zucker rats. J Lipid Res 2002;43:1855-63.
  • 8Cha BS, Ciaraldi TP, Park KS, Carter L, Mudaliar SR, Henry RR.Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists. Am J Physiol Endocrinol Metab 2005; 289: E151-9.
  • 9Sinha S, Perdomo G, Brown NF, O'Doherty RM. Fatty acidinduced insulin resistance in 16 myotubes is prevented by inhibition of activation and nuclear localization of nuclear factor kappa B. J Biol Chem 2004; 279: 41294-301.
  • 10Wiegman CH, Bandsma RH, Ouwens M, van der Sluijs FH, Havinga R, Boer T, et al. Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin. Diabetes 2003; 52: 1081-9.

共引文献3

同被引文献6

引证文献1

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部